Risk assessment and HbA1c measurement in Norwegian community pharmacies to identify people with undiagnosed type 2 diabetes - A feasibility study

PloS One
Aslaug Johanne RisøyUna Ørvim Sølvik

Abstract

Determine the feasibility of using a diabetes risk assessment tool followed by HbA1c-measurement in a community-pharmacy setting in Norway. In this longitudinal study two pharmacists in each of three community pharmacies were trained to perform risk assessments, HbA1c-measurements and counselling. Pharmacy customers who were > 18 years old and could understand and speak Norwegian or English were recruited in the pharmacies during a two-months-period. Information about the service was presented in local newspapers, social media, leaflets and posters at the pharmacy. Customers wishing to participate contacted the pharmacy staff. Participants completed a validated diabetes risk test and a background questionnaire including a validated instrument for self-rated health. A HbA1c measurement was performed for individuals with a moderate to high risk of developing diabetes. If HbA1c ≥ 6.5% they were recommended to visit their general practitioner for follow-up. The pharmacies performed internal and external quality control of the HbA1c instrument. Of the 211 included participants 97 (46%) were > 50 years old. HbA1c was measured for the 47 participants (22%) with high risk. Thirty-two (15%) had HbA1c values < 5.7%, twelve (5.4%) had val...Continue Reading

References

Sep 19, 2001·Health & Social Care in the Community·Karen HassellPeter Noyce
Mar 1, 2003·Diabetes Care·Jaana Lindström, Jaakko Tuomilehto
Sep 28, 2006·Pharmacy World & Science : PWS·Kurt E HersbergerRudolf Bruppacher
Jun 4, 2008·Annals of Internal Medicine·Susan L NorrisUNKNOWN U.S. Preventive Services Task Force
Dec 25, 2008·Medical Care·Philip M ClarkeAnthony C Keech
Jun 9, 2009·Diabetes Care·UNKNOWN International Expert Committee
Jul 27, 2010·Diabetic Medicine : a Journal of the British Diabetic Association·L J GrayM J Davies
Jul 30, 2011·BMC Public Health·Ruth E CollinsTheresa M Marteau
Nov 20, 2012·International Journal of Nursing Studies·Peter CraigMark Petticrew
Mar 20, 2013·Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC·John PapastergiouPeter Tolios
Apr 1, 2008·Pharmacy Practice·Elin C LarssonCecilia Stålsby-Lundborg
Sep 25, 2014·International Journal of Medical Sciences·Yanling WuWen Zhang
Mar 11, 2015·Annals of Family Medicine·Justin B Echouffo-TcheuguiSimon J Griffin
Mar 31, 2015·Diabetes Research and Clinical Practice·Narjis Fikri-BenbrahimDaniel Sabater-Hernández
Sep 19, 2015·BMC Health Services Research·Rapeepong SuphanchaimatPhusit Prakongsai
Dec 17, 2015·The International Journal of Pharmacy Practice·John PapastergiouWilson Li
Dec 17, 2016·Diabetes Care·UNKNOWN American Diabetes Association

❮ Previous
Next ❯

Citations

Dec 2, 2020·Journal of the American Pharmacists Association : JAPhA·Bernadette D Asias-Dinh, Kevin W Garey
Jun 23, 2021·Research in Social & Administrative Pharmacy : RSAP·Aslaug Johanne RisøyUna Ørvim Sølvik

❮ Previous
Next ❯

Software Mentioned

EQA
SPSS Statistics
FINDRISC

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

© 2022 Meta ULC. All rights reserved